LOS ANGELES/LONDON (Reuters) - AstraZeneca Plc has won U.S. approval to market its cholesterol-lowering drug Crestor to treat the clogging of arteries, which may boost sales of the blockbuster drug in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results